Mohamed Genead, MD

An Ophthalmologist and Medical retina specialist and a senior biopharamceutical executive leader with more than 15 years of experience in Ophthalmology clinical research. Most recently served as Biogen Global Therapeutic Area Head of Ophthalmology and Retina Gene Therapy. Prior to joining Biogen, Mohamed was Head of Clinical Development at Allegro Ophthalmic. Prior to joining Allegro, Mohamed was Global project and clinical teams Lead for early proof of concept and late development programs in retina at Allergan, where he led projects as DARPins for wet AMD and DME.Mohamed spent years in academia serving as co-director of center for retina degenerative diseases, as an investigator and as clinician at University of Illinois in Chicago. He was the primary and key author for numerous key peer-reviewed manuscripts.